바이오산업본부

1.Linearmode 1)Resolution:≥6,000forACTH18-39(m/z2,465)FWHM 2)Massaccuracy:≤30ppmwithinternallcalibration 3)Sensitivity:250amol[Glu1]-FibrinopeptideB(m/z1,570.7)atS/N≥20:1 2.Reflectormode 1)Resolution:≥25,000(FWHM)forSomatostatin28(m/z3,147.47) 2)Massaccuracy:≤ 3 ppm with internal calibration 3)Sensitivity:250amol[Glu1]-FibrinopeptideB(m/z1,570.7)atS/N≥100:1 3.LID-LIFTMethod 1)Theiongatefortheprecursorionselectionhasaresolutionof≥750. 2)MS/MSsensitivity:250amol[Glu1]-FibrinopeptideB(m/z1,056)atS/N≥10:1 3)MS/MSMassAccuracy:AverageMassError≤0.05Da 4)MS/MSfragmentresolution:≥4,500for[Glu1]-Fibfragmentm/z1,441 4. CID (Collision Induced Dissociation) mode. S/N of d6≥10:1 5.AvailableTOF-TOFmode : LID-LIFT,CID-LIFT,ISD-LIFT,T3Sequencingshouldbesupported